Atlas Trials

Safety and Efficacy of Alogliptin in Indian Participants With Type 2 Diabetes Mellitus

Clinical trial NCT03042325 · WITHDRAWN

Trial details

NCT number
NCT03042325
Sponsor
Takeda
Status
WITHDRAWN
Phase
Phase 4
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 2
Start date
2017-07-30
Primary completion
2018-01-15
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.